Search - tctmd.com

Displaying 961 - 980 of 1062

Sort: Relevancy | Date

Presentation CTO 2012

Can Left Main Severity Be Assessed Angiographically?

Presenter: Sorin Brener

February 22, 2012

Presentation CTO 2012

Assessment of Left Main Lesions by IVUS: When and What Criteria?

Presenter: Akiko Maehara

February 22, 2012

Presentation CTO 2012

Assessment of Left Main Lesions by FFR: When and What Criteria?

Presenter: Morton Kern

February 22, 2012

Presentation CTO 2012

2011/2012 Essential Left Main Update: Rapid Review of All Essential Left Main Publications and Abstracts from the Last Year

Presenter: David Kandzari

February 22, 2012

News Industry News

4000th Patient Treated With Innovative Tryton Side Branch Stent

February 14, 2012

News Daily News

CMS Publishes Proposed TAVR Coverage Conditions

Caitlin E. Cox

February 07, 2012

Presentation

Characteristics and Long-term Outcomes of Percutaneous Revascularization of Unprotected Left Main Coronary Artery Stenosis in the United States

Presenter: J. Matthew Brennan

February 05, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Daily News

New Revascularization Appropriateness Criteria Feature PCI Upgrades

January 31, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

Presentation TCT 2012

Frequency and Distribution of Thin-Capped Fibroatheroma in the Left Main Coronary Artery: A Virtual Histology Intravascular Ultrasound Analysis

Presenter: Sang-Wook Kim, Gary S. Mintz, Wang Soo Lee, Jee Eun Kwon, Min Seok Oh, Kwang Je Lee, Chee Jeong Kim, Tae Ho Kim, Neil J. Weissman

January 03, 2012

Presentation TCT 2012

Outcomes Following Unprotected Left Main Stenting with Everolimus-Eluting Stents: the Milan Experience.

Presenter: Gill L. Buchanan, Alfonso Ielasi, Alaide Chieffo, Matteo Montorfano, Cosmo Godino, Azeem Latib, Mauro Carlino, Antonio Colombo

January 03, 2012

Presentation TCT 2012

Left Main to Left Anterior Descending Artery Or Left Main to Circumflex Stenting? This is the Question.

Presenter: Marco Di Cuia, Chiara Resmini, Flavia Ballocca, Mario Bollati, Sara Sturnia, Claudio Moretti, Pier Luigi Omed?, Filippo Sciuto, Giuseppe Biondi Zoccai, Fiorenzo Gaita, Imad Sheiban

January 03, 2012

Presentation TCT 2012

Left Main Percutaneous Coronary Intervention in Spain. The National Registry RENACIMIENTO.

Presenter: Agustin Albarran G-Trevilla, Jose Antonio Baz, Josefa Mauri, Eduardo Pinar, Eulogio Garcia, Sergio Rodriguez de Leiras, Monica Masotti, Margot Aguilar, Javier Fernandez Portales, Ricardo Fajardo

January 03, 2012

Presentation TCT 2012

Left Main Bifurcation Stenting: Long Term Followup of Simultaneous Kissing Stents in 140 Consecutive, Unselected Patients

Presenter: Julian Gunn, Anjan Siotia, Chris Malkin, Tushar Raina, Allison C. Morton

January 03, 2012

Presentation TCT 2012

Impact of Initial Procedure and Revascularization Strategy on the Treatment of Drug-Eluting Stent Restenosis Following Unprotected Distal Left Main PCI: the Milan and...

Presenter: Kensuke Takagi, Alfonso Ielasi, Joanne Shannon, Azeem Latib, Cosmo Godino, Giedrius Davidavicius, Marco Mussardo, Santo Ferrarello, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Sunao Nakamura, Antonio Colombo

January 03, 2012

Presentation TCT 2012

Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease and/or Left Main Disease

Presenter: David R. Holmes, Brad Vazales, Louis A. Cannon, Elisabeth Stahle, Marie-Claude Morice, Michael J. Mack, Ted E. Feldman, A. Pieter Kappetein, Antonio Colombo, Keith D. Dawkins, Friedrich W. Mohr, Patrick W. Serruys

January 03, 2012

Presentation TCT 2012

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

January 03, 2012

Presentation TCT 2012

First Generation versus Newer Generation Drug-eluting Stents in Unprotected Left Main Coronary Artery Intervention

Presenter: Amro Elnagar, Seung Woon Rha, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Presentation TCT 2012

Favorable Long-Term Clinical Outcomes Of Intravascular Ultrasound-Guided Provisional Single Stent Strategy for Feasible Unprotected Left Main Trunk Distal Bifurcation Lesions

Presenter: Takayoshi Toba, Shinichiro Yamada, Takatoshi Hayashi, Shougo Oishi, Kiminobu Yokoi, Naoki Miyoshi, Gaku Kanda, Tomofumi Takaya, Koji Fukuzawa, Katsunori Okajima, Akira Shimane, Yasuyo Taniguchi, Mitsuhiro Yokoyama

January 03, 2012

Advertisement

Can Left Main Severity Be Assessed Angiographically?

Assessment of Left Main Lesions by IVUS: When and What Criteria?

Assessment of Left Main Lesions by FFR: When and What Criteria?

2011/2012 Essential Left Main Update: Rapid Review of All Essential Left Main Publications and Abstracts from the Last Year

4000th Patient Treated With Innovative Tryton Side Branch Stent

CMS Publishes Proposed TAVR Coverage Conditions

Characteristics and Long-term Outcomes of Percutaneous Revascularization of Unprotected Left Main Coronary Artery Stenosis in the United States

Novel Strategies Advance Cell Therapy for Cardiomyopathy

New Revascularization Appropriateness Criteria Feature PCI Upgrades

Expedited Cell Therapy After STEMI Shows Promise

Frequency and Distribution of Thin-Capped Fibroatheroma in the Left Main Coronary Artery: A Virtual Histology Intravascular Ultrasound Analysis

Outcomes Following Unprotected Left Main Stenting with Everolimus-Eluting Stents: the Milan Experience.

Left Main to Left Anterior Descending Artery Or Left Main to Circumflex Stenting? This is the Question.

Left Main Percutaneous Coronary Intervention in Spain. The National Registry RENACIMIENTO.

Left Main Bifurcation Stenting: Long Term Followup of Simultaneous Kissing Stents in 140 Consecutive, Unselected Patients

Impact of Initial Procedure and Revascularization Strategy on the Treatment of Drug-Eluting Stent Restenosis Following Unprotected Distal Left Main PCI: the Milan and...

Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease and/or Left Main Disease

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

First Generation versus Newer Generation Drug-eluting Stents in Unprotected Left Main Coronary Artery Intervention

Favorable Long-Term Clinical Outcomes Of Intravascular Ultrasound-Guided Provisional Single Stent Strategy for Feasible Unprotected Left Main Trunk Distal Bifurcation Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content